Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions

Objectives To assess the safety and efficacy of fractional flow reserve (FFR) guided paclitaxel‐coated balloon (PCB) treatment for de novo coronary artery lesions. Background: There is limited data on PCB treatment for de novo lesions especially of major epicardial coronary arteries. Methods Sixty‐s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Catheterization and cardiovascular interventions 2016-08, Vol.88 (2), p.193-200
Hauptverfasser:	Shin, Eun-Seok, Ann, Soe Hee, Balbir Singh, Gillian, Lim, Kyung Hun, Kleber, Franz X., Koo, Bon-Kwon
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary - adverse effects Angioplasty, Balloon, Coronary - instrumentation Cardiac Catheters Cardiovascular Agents - administration & dosage Cardiovascular Agents - adverse effects Coated Materials, Biocompatible Coronary Angiography Coronary Artery Disease - diagnosis Coronary Artery Disease - physiopathology Coronary Artery Disease - therapy Coronary Restenosis - etiology Coronary Vessels - drug effects Coronary Vessels - physiopathology de novo lesion Drug Therapy, Combination Drug-Eluting Stents Equipment Design Female fractional flow reserve Fractional Flow Reserve, Myocardial - drug effects Heart attacks Humans late luminal loss Male Middle Aged Myocardial Infarction - etiology Paclitaxel - administration & dosage Paclitaxel - adverse effects paclitaxel-coated balloon plain old balloon angioplasty Platelet Aggregation Inhibitors - administration & dosage Predictive Value of Tests Prospective Studies Registries Republic of Korea Stents Time Factors Treatment Outcome Vascular Patency - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objectives To assess the safety and efficacy of fractional flow reserve (FFR) guided paclitaxel‐coated balloon (PCB) treatment for de novo coronary artery lesions. Background: There is limited data on PCB treatment for de novo lesions especially of major epicardial coronary arteries. Methods Sixty‐six patients with 67 de novo lesions who underwent successful plain old balloon angioplasty (POBA) were included. If POBA‐FFR was favorable (≥ 0.85), PCB was applied and if POBA‐FFR was
ISSN:	1522-1946 1522-726X
DOI:	10.1002/ccd.26257